Aptus Pharma Limited
ListedSMEHealthcare · BSE
Aptus Pharma Ltd, incorporated in 2010, is engaged in the marketing and distribution of finished pharmaceutical formulations. The company manufactures and distributes a wide range of products across multiple therapeutic areas including antacids and PPIs, pain management, anti-inflammatories, antibiotics, cardiology and antidiabetics, neuropsychiatry, dental, injectable parenterals, syrups, nutraceuticals, and sachets. Its business divisions include Aptus Pharma, which focuses on acute therapies such as anti-infectives and pain management; Aptus CD Care, which specializes in chronic therapies; Aptus Wellcare, which offers wellness and nutraceutical products; and Aptus Global, which caters to the export market. As of March 31, 2025, the company had developed 194 pharmaceutical formulations across more than eleven therapeutic segments. It operates warehouses covering 15,732 sq. feet and 1,989 sq. feet in Ahmedabad, Gujarat. The company’s distribution network consists of 125 direct and sub-distributors supported by a sales team of 54 field personnel, and it employed 70 people as of March 31, 2025.
Price Band
₹65 – ₹70
Issue Size
₹13.02 Cr
Lot Size
2000 shares
GMP
₹4
+5.7%
Est. Listing
₹74
at current GMP
Subscribed
21.48x
overall
Open
23 Sep 2025
Close
25 Sep 2025
Allotment
26 Sep 2025
Refund
27 Sep 2025
Demat Credit
28 Sep 2025
Listing
30 Sep 2025
Last updated 12 days ago
Overall Subscription
21.48x
Total Demand
QIB Multiplier
1.22x
Institutions & Funds
NII / HNI
28.68x
High Net-Worth
Retail (RII)
29.90x
Individual Bidders
Category-Wise Subscription Breakup
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| QIB | 352,000 | 430,000 | 1.22x |
| NIB | 266,000 | 7,628,000 | 28.68x |
| HNIs(10L +) | 178,000 | 5,548,000 | 31.17x |
| HNIs (2-10L) | 88,000 | 2,080,000 | 23.64x |
| RETAIL | 620,000 | 18,536,000 | 29.90x |
| Total | 1,504,000 | 34,222,000 | 21.48x |
Application-Wise Breakup
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| QIB | — | 2 | 0.00x |
| NIB | — | 629 | 0.00x |
| RETAIL | 155 | 4,608 | 29.73x |
| HNIs(10L +) | 30 | 323 | 10.77x |
| HNIs (2-10L) | 15 | 306 | 20.40x |
| Total Applications | 200 | 5,868 | 29.34x |
Day-Wise Subscription Progress
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
About Aptus Pharma Limited Public Issue & Market Profile
Aptus Pharma Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹13.02 Crores. The shares are offered at a price band of ₹65 to ₹70 per equity share on BSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Bidding & Quota Instructions:
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 2000 shares (approx. ₹1,40,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment Reconciliation Schedule:
Allotment reconciliation will be managed by Bigshare Services Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2025-09-28, while un-allotted funds or UPI block mandates will be released on 2025-09-27.
Frequently Asked Questions
What is Aptus Pharma Limited IPO GMP today?
The latest Grey Market Premium (GMP) for Aptus Pharma Limited IPO is ₹4 per equity share. Based on the upper price band of ₹65 to ₹70 per equity share, the estimated listing price is ₹74 (+5.7% expected listing gain).
What is the expected profit per lot for Aptus Pharma Limited IPO?
With a lot size of 2000 shares and current GMP of ₹4, the expected profit per application lot is approx ₹8,000 (+5.7% gain). Minimum application cost is approx ₹1,40,000.
What is the issue size and price band for Aptus Pharma Limited IPO?
The Aptus Pharma Limited IPO aggregate issue size is ₹13.02 Crores with an equity price band set at ₹65 to ₹70 per equity share. The retail lot size is 2000 shares requiring a minimum capital outlay of approx. ₹1,40,000.
How can I check Aptus Pharma Limited IPO live subscription demand?
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 21.48x (Retail: 29.90x, QIB: 1.22x, NII: 28.68x). You can track live multiples directly on our dedicated subscription page.
Where and when will Aptus Pharma Limited IPO allotment status be published?
The basis of allotment will be published on the official registrar portal (Bigshare Services Private Limited) and the BSE status verification website on or around 2025-09-26. Investors can verify status using PAN card or application number.
When is the listing date for Aptus Pharma Limited IPO?
Aptus Pharma Limited shares are scheduled to list on BSE on 2025-09-30.